Literature DB >> 2578695

Androgen receptors in bladder tumors.

E Laor, Z J Schiffman, J D Braunstein, R E Reid, B M Tolia, L G Koss, S Z Freed.   

Abstract

Cytosol androgen receptor content of transitional cell bladder cancer tissue was found to be substantially higher than its content in normal bladder mucosa and lower than in control benign prostatic hypertrophy tissue. Tumors arising in female patients had a lower androgen receptor content than those arising in male patients. High-grade tumors had a lower androgen receptor content than low-grade tumors.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2578695     DOI： 10.1016/0090-4295(85)90534-5

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  10 in total

1.  Androgen receptors in transitional cell carcinoma.

Authors:  Z Kirkali; S Cowan; R E Leake
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Implication of androgen receptor in urinary bladder cancer: a critical mini review.

Authors:  Arshad H Rahmani; Mohammad Alzohairy; Ali Yousif Y Babiker; Amjad A Khan; Salah M Aly; Moshahid A Rizvi
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

3.  Bladder cancer, parity, and age at first birth.

Authors:  K P Cantor; C F Lynch; D Johnson
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

4.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

5.  The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.

Authors:  Chih-Rong Shyr; Chi-Cheng Chen; Teng-Fu Hsieh; Chao-Hsiang Chang; Wen-Lung Ma; Shuyuan Yeh; Edward Messing; Tsung-Heng Li; Fu-Yin Li; Chawnshang Chang
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

6.  Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis.

Authors:  Kimberley Katleba; Alan P Lombard; Maria-Malvina Tsamouri; Han Bit Baek; Kristine S Nishida; Stephen J Libertini; Alexander J Platero; Ai-Hong Ma; Chong-Xian Pan; Paramita M Ghosh; Maria Mudryj
Journal:  Cancer Lett       Date:  2021-02-04       Impact factor: 8.679

Review 7.  Androgen Receptor Signaling in Bladder Cancer.

Authors:  Peng Li; Jinbo Chen; Hiroshi Miyamoto
Journal:  Cancers (Basel)       Date:  2017-02-22       Impact factor: 6.639

Review 8.  Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.

Authors:  Jianjian Li; Zhe Ming; Liuyi Yang; Tingxuan Wang; Gaowen Liu; Qing Ma
Journal:  Genes Dis       Date:  2022-04-29

9.  Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

Authors:  Aimee M Johnson; Mary J O'Connell; Hiroshi Miyamoto; Jiaoti Huang; Jorge L Yao; Edward M Messing; Jay E Reeder
Journal:  BMC Urol       Date:  2008-04-23       Impact factor: 2.264

Review 10.  Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.

Authors:  Guilherme Godoy; Georgios Gakis; Carolyn L Smith; Omar Fahmy
Journal:  Bladder Cancer       Date:  2016-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.